FDA must soon update Congress on its plan for regulating cannabidiol (CBD) products, but there are myriad issues the agency still needs to grapple with as that deadline looms. The agency has consistently said it needs more data on CBD and its health effects, and it has yet to clarify whether it will allow CBD in food and dietary supplements. Once it makes a decision on what products can contain CBD, experts wonder how FDA will exercise its enforcement authority...